Skip to content
Toggle Navigation
Why Quantum
Quantum Computing Today
Quantum vs. Traditional Screening
Quantum Computing vs. AI
QuADD Solutions
Hits & Leads
Joint Development
Pipeline
Platform
Who We Serve
Pharma
Biotech
Agriculture
CROs
Resources
Blog
Whitepapers
Webinars
Publications
Company
About Us
Customers
Partners
News
Team
Contact Us
Toggle Navigation
Why Quantum
Quantum Computing Today
Quantum vs. Traditional Screening
Quantum Computing vs. AI
QuADD Solutions
Hits & Leads
Joint Development
Pipeline
Platform
Who We Serve
Pharma
Biotech
Agriculture
CROs
Resources
Blog
Whitepapers
Webinars
Publications
Company
About Us
Customers
Partners
News
Team
Contact Us
POLARISqb and Fujitsu
[vc_row][vc_column][vc_column_text]
POLARIS
qb
and Fujitsu announces pioneering drug discovery platform to speed up the process of bringing new drugs to market
[/vc_column_text][/vc_column][/vc_row]
Published On: March 16th, 2020
Categories:
Blog
,
News
Tags:
Chemistry
,
Digital Annealer
,
Drug Discovery
,
Futurism
,
Machine Learning
,
Press Release
,
Protein Targeting
Share this story, choose your platform!
Search
Search for:
Recent Posts
PTG and PolarisQB Announce Exclusive Representation Agreement for Greater China and Southeast Asia
June 19, 2026
PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline
April 14, 2026
Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program
April 14, 2026
Categories
Blog (16)
News (49)
Page load link
Go to Top